Bone Marrow Transplantation
📧 Sign up to get email alerts when something new happens for Bone Marrow Transplantation.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-24EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Authorised status for Privigen (human normal immunoglobulin IVIg) by CSL Behring GmbH in the EMA; therapeutic areas include various immunolo…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Hemofiltration for Respiratory Failure After Bone Marrow Transplantation [Phase 2, Phase 3]
Clinical trial update on hemofiltration for respiratory failure following bone marrow transplantation reported as completed (Phase 2/Phase 3…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Spanish BMT4me Usability & Acceptability
A completed clinical trial update evaluating the usability and acceptability of the Spanish version of the BMT4me platform for bone marrow t…
-
EMA approval · 2025-05-28EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Privigen (human normal immunoglobulin IVIg) has been authorised by the EMA for multiple indications. The listed therapeutic areas include id…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant [Phase 2]
Phase 2 trial evaluating eltrombopag olamine for increasing platelet counts in patients undergoing bone marrow or cord blood hematopoietic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-01-11EMA Authorised: Flebogamma DIF (previously Flebogammadif) (human normal immunoglobulin) — Instituto Grifols S.A.
EMA authorises Flebogamma DIF (human normal immunoglobulin) for multiple immunological indications including mucocutaneous lymph node syndro…
-
FDA approval · 2023-08-28FDA Approved: NIVESTYM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for NIVESTYM (filgrastim-aafi) from Pfizer Laboratories Div Pfizer Inc.
-
EMA approval · 2022-06-27EMA Authorised: Kiovig (human normal immunoglobulin (IVIg)) — Takeda Manufacturing Austria AG
Kiovig (human normal immunoglobulin IVIg) has been authorised by EMA for multiple indications including immune thrombocytopenic purpura, bon…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: King's Invasive Aspergillosis Study II [Phase 4]
A Phase 4 clinical trial update for King's Invasive Aspergillosis Study II (NCT02875743) from King's College Hospital NHS Trust, with condit…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients [Phase 2]
Phase 2 clinical trial assessing music therapy-based stress reduction in bone marrow transplant and stem cell transplant recipients has comp…